Xyratex (XRTX) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrendsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 6 at 5:30 PM | globenewswire.comXORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of ShareholdersSeptember 3, 2024 | globenewswire.comIndependent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of ShareholdersAugust 30, 2024 | benzinga.comXORTX Therapeutics (NASDAQ:XRTX) Stock, Short Interest ReportAugust 23, 2024 | globenewswire.comXORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of ShareholdersAugust 20, 2024 | globenewswire.comXORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024August 4, 2024 | theglobeandmail.comClosing Bell: Xortx Therapeutics Inc down on Friday (XRTX)May 20, 2024 | msn.comXRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024May 17, 2024 | globenewswire.comXORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPOApril 30, 2024 | globenewswire.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsApril 26, 2024 | ca.finance.yahoo.comXORTX Therapeutics Inc. (XRTX.V)April 22, 2024 | globenewswire.comXORTX Announces Publication of Key Research in ADPKDApril 8, 2024 | globenewswire.comXORTX Welcomes New Member to the Board of DirectorsApril 5, 2024 | morningstar.comXORTX Therapeutics Inc XRTXApril 1, 2024 | nasdaq.comXORTX Therapeutics Inc. Common Stock (XRTX)March 27, 2024 | globenewswire.comXORTX Announces New Clinical Advisory Board MemberMarch 19, 2024 | finance.yahoo.comXORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical TrialMarch 19, 2024 | globenewswire.comXORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialMarch 11, 2024 | finance.yahoo.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsMarch 7, 2024 | marketbeat.comTrading was temporarily halted for "XRTX" at 09:03 AM with a stated reason of "LULD pause."March 4, 2024 | globenewswire.comXORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 15, 2024 | finance.yahoo.comXORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 2, 2024 | finance.yahoo.comXORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsJanuary 15, 2024 | finance.yahoo.comXORTX Announces $2 Million Public OfferingJanuary 5, 2024 | benzinga.comXORTX Therapeutics Stock (NASDAQ:XRTX), Analyst Ratings, Price Targets, PredictionsJanuary 3, 2024 | finance.yahoo.comXORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNovember 30, 2023 | finance.yahoo.comXORTX Announces US ATM OfferingNovember 29, 2023 | finance.yahoo.comXORTX Meets Nasdaq Continued Listing RequirementsNovember 14, 2023 | marketbeat.comTrading was temporarily halted for "XRTX" at 07:11 PM with a stated reason of "News pending."November 10, 2023 | finance.yahoo.comXORTX Clarifies Timing for Share ConsolidationNovember 10, 2023 | marketbeat.comTrading was temporarily halted for "XRTX" at 07:11 PM with a stated reason of "News pending."November 8, 2023 | finance.yahoo.comXORTX Announces Share ConsolidationNovember 2, 2023 | finance.yahoo.comXORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023October 27, 2023 | finance.yahoo.comXORTX Announces Results of Special Meeting of ShareholdersOctober 25, 2023 | finance.yahoo.comXORTX Announces Date for Rescheduled Special Meeting of ShareholdersOctober 25, 2023 | finance.yahoo.comXORTX Announces Rescheduling of Special Meeting of ShareholdersOctober 4, 2023 | finance.yahoo.comXORTX Calls Special Meeting of ShareholdersSeptember 28, 2023 | finance.yahoo.comXORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023September 7, 2023 | finance.yahoo.comXORTX Joins the Kidney Foundation and Kidney MarchAugust 29, 2023 | finance.yahoo.comXORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney DiseaseAugust 23, 2023 | thestreet.comA Christmas-Comes-Early PortfolioAugust 4, 2023 | finance.yahoo.comXORTX Appoints Chief Financial OfficerJune 29, 2023 | finance.yahoo.comXORTX Announces Results of Annual and Special Meeting of ShareholdersJune 6, 2023 | finance.yahoo.comXORTX Announces PKD PresentationMay 24, 2023 | finance.yahoo.comXORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price DeficiencyMay 6, 2023 | msn.comXORTX Therapeutics' Xorlo eligible for accelerated approval, confirms FDAMay 4, 2023 | finance.yahoo.comFDA Confirms Eligibility of XORLO™ for Accelerated ApprovalApril 21, 2023 | finance.yahoo.comXORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney DiseaseMarch 14, 2023 | finance.yahoo.comXORTX Announces Type D Meeting with FDA to be held May 1, 2023February 7, 2023 | finance.yahoo.comXORTX Provides Update on 2022 Achievements and 2023 Planned MilestonesFebruary 1, 2023 | finance.yahoo.comXORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden's Successor: The Radical Threat to YOUR Savings! (Ad)Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL. >> Get Your FREE Wealth Protection Guide << XRTX Media Mentions By Week XRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XRTX News Sentiment▼0.000.55▲Average Medical News Sentiment XRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XRTX Articles This Week▼20▲XRTX Articles Average Week Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NRXP News KALA News TLPH News SYBX News BIVI News HCWB News GLMD News APM News SNSE News AYTU News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XRTX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
